(Q38329529)

2 September 2017

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines (English)

1 reference

2 September 2017

0 references

Rajiv Kumar

7

0 references

Selma Ugurel

series ordinal

5

object named as

Selma Ugurel

1 reference

2 September 2017

6

Dirk Schadendorf

1 reference

2 September 2017

3

Kari Hemminki

1 reference

2 September 2017

Sandra Bloethner

1

1 reference

2 September 2017

Bowang Chen

series ordinal

2

1 reference

2 September 2017

Jan Müller-Berghaus

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

10 March 2005

1 reference

2 September 2017

1 reference

2 September 2017

26

1 reference

2 September 2017

1224-1232

1 reference

2 September 2017

7

1 reference

describes a project that uses

2 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

The regulation of normal melanocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

BRAF mutations are common somatic events in melanocytic nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

V599EB-RAF is an oncogene in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Immunogenicity of constitutively active V599EBRaf

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Deregulated Akt3 activity promotes development of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Regulation of Raf-1 by direct feedback phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

ETS transcription factors: possible targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Krüppel-like factors: three fingers in many pies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

Tumour biological aspects of CD24, a mucin-like adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI066

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGI066

1 reference

2 September 2017

1 reference